Gri bio (nasdaq: gri) reports second quarter 2023 financial results and provides corporate update

Rapidly advancing c linical pipeline across multiple high-value i nflammatory, f ibrotic and a utoimmune d iseases
GRI Ratings Summary
GRI Quant Ranking